Henrik Teller studied chemistry at the University of Leipzig and Ohio University. Subsequently, he moved to Max-Planck-Institute of coal research for his Ph.D. thesis in asymmetric gold(I)-catalysis. In 2012, he joined the University of Cambridge as a postdoctoral research assistant dedicated to the total synthesis of marine natural products. In 2013, he was appointed to a lab-head in pre-clinical lead optimization at BAYER Pharma AG working in cardiovascular research. Since mid-2016, he holds the position of the Business Development Manager at micromod Partikeltechnologie GmbH.